Jane Street’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Jane Street’s Portfolio MACK Stock Details MACK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-1,538	Closed	-$150K	–	4477
2015 Q2	$150K	Buy	+1,538	New	+$146K	﹤0.01%	3346

Other funds holding MACK

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

Rise Advisors Rochester, New York $355M AUM 20.51% 1-Year Est. Return

JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Jane Street's MACK Position: Q2 2024 in Review

Jane Street sold out of Merrimack Pharmaceuticals, Inc. (MACK) in Q2 2024, closing a stake of 11,124 shares — an estimated $164K sold.

Jane Street first reported a position in MACK in Q2 2013 and held it in 13 quarters. The position peaked at $2.83M in Q3 2014. 12 funds tracked by Wall St. Rank hold MACK as of Q2 2024.

Jane Street reported no remaining Merrimack Pharmaceuticals, Inc. position as of Q2 2024 after selling out during the quarter.
Jane Street sold 11,124 Merrimack Pharmaceuticals, Inc. shares in Q2 2024, an estimated $164K.
Jane Street first reported a position in Merrimack Pharmaceuticals, Inc. in Q2 2013 and held it in 13 quarters.
Jane Street's Merrimack Pharmaceuticals, Inc. position peaked at $2.83M in Q3 2014.
12 funds tracked by Wall St. Rank held Merrimack Pharmaceuticals, Inc. as of Q2 2024.

Based on Jane Street's 13F filing for Q2 2024, filed 15 Aug 2024.